[HTML][HTML] CTLA-4 mediates inhibitory function of mesenchymal stem/stromal cells

T Gaber, K Schönbeck, H Hoff, CL Tran… - International journal of …, 2018 - mdpi.com
T Gaber, K Schönbeck, H Hoff, CL Tran, C Strehl, A Lang, S Ohrndorf, M Pfeiffenberger
International journal of molecular sciences, 2018mdpi.com
Mesenchymal stem/stromal cells (MSCs) are stem cells of the connective tissue, possess a
plastic phenotype, and are able to differentiate into various tissues. Besides their role in
tissue regeneration, MSCs perform additional functions as a modulator or inhibitor of
immune responses. Due to their pleiotropic function, MSCs have also gained therapeutic
importance for the treatment of autoimmune diseases and for improving fracture healing and
cartilage regeneration. However, the therapeutic/immunomodulatory mode of action of …
Mesenchymal stem/stromal cells (MSCs) are stem cells of the connective tissue, possess a plastic phenotype, and are able to differentiate into various tissues. Besides their role in tissue regeneration, MSCs perform additional functions as a modulator or inhibitor of immune responses. Due to their pleiotropic function, MSCs have also gained therapeutic importance for the treatment of autoimmune diseases and for improving fracture healing and cartilage regeneration. However, the therapeutic/immunomodulatory mode of action of MSCs is largely unknown. Here, we describe that MSCs express the inhibitory receptor CTLA-4 (cytotoxic T lymphocyte antigen 4). We show that depending on the environmental conditions, MSCs express different isoforms of CTLA-4 with the secreted isoform (sCTLA-4) being the most abundant under hypoxic conditions. Furthermore, we demonstrate that the immunosuppressive function of MSCs is mediated mainly by the secretion of CTLA-4. These findings open new ways for treatment when tissue regeneration/fracture healing is difficult.
MDPI